Graftoss

Graftoss

Graftoss Limited is a medical device company which is developing a bone implant sourced from bovine bone for use by surgeons and veterinarians. The processed bone has its indigenous organic compounds removed, and is then reinforced with an organic biocompatible matrix, providing mechanical strength and aiding in bone regeneration.

Objective

WaikatoLink are seeking companies or research organisations interested in licensing and developing the technology.

Unique Selling Propositions
  • The naturally occurring reinforcing compound enhances osteo induction and osteo conduction
  • The bovine bone is sourced from a naturally free BSE free herd
  • Through processing the bone matrix retains its macro and micro porous structures
  • Improved
Applications
  • Graftoss's bone matrix technology has applications as a xenograft material for human and veterinary grafting, including spinal fusion, hand and foot surgery, simple and complex fractures repair, joint reconstruction and dental implants, and as an antibi
IP Strategy

Granted patent in NZ. National phase applications lodged

Project Status

Proof of Concept - Early prototype built